JENNIFER HOYT: Open Payments
NPI 1851328462 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 35 payments from 13 companies in 2025. Trend: 2023 $821 · 2024 $680 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $165 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| PFIZER INC. | 3 | $75 |
| ABBVIE INC. | 3 | $51 |
| Lundbeck LLC | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
Products named: AIRSUPRA, PREVNAR 20, Repatha, EVENITY, REXULTI, XIFAXAN, OTEZLA, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
